| Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells K Le Blanc, I Rasmusson, B Sundberg, C Götherström, M Hassan, ... The Lancet 363 (9419), 1439-1441, 2004 | 3725 | 2004 |
| Dynamics of fat cell turnover in humans KL Spalding, E Arner, PO Westermark, S Bernard, BA Buchholz, ... Nature 453 (7196), 783-787, 2008 | 3032 | 2008 |
| Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1 MG Ott, M Schmidt, K Schwarzwaelder, S Stein, U Siler, U Koehl, H Glimm, ... Nature medicine 12 (4), 401-409, 2006 | 1413 | 2006 |
| Repurposed antiviral drugs for Covid-19—interim WHO solidarity trial results WHO Solidarity Trial Consortium New England journal of medicine 384 (6), 497-511, 2021 | 872 | 2021 |
| Fetal mesenchymal stem-cell engraftment in bone after in utero transplantation in a patient with severe osteogenesis imperfecta K Le Blanc, C Götherström, O Ringdén, M Hassan, R McMahon, E Horwitz, ... Transplantation 79 (11), 1607-1614, 2005 | 585 | 2005 |
| Inhibition of proteasome deubiquitinating activity as a new cancer therapy P D'arcy, S Brnjic, MH Olofsson, M Fryknäs, K Lindsten, M De Cesare, ... Nature medicine 17 (12), 1636-1640, 2011 | 579 | 2011 |
| Reduced-intensity conditioning and HLA-matched haemopoietic stem-cell transplantation in patients with chronic granulomatous disease: a prospective multicentre study T Güngör, P Teira, M Slatter, G Stussi, P Stepensky, D Moshous, ... The Lancet 383 (9915), 436-448, 2014 | 367 | 2014 |
| Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses H Pan, R Peto, AMH Restrepo, MP Preziosi, V Sathiyamoorthy, QA Karim, ... The Lancet 399 (10339), 1941-1953, 2022 | 301 | 2022 |
| Role of polymorphic human CYP2B6 in cyclophosphamide bioactivation HJ Xie, Ü Yasar, S Lundgren, L Griskevicius, Y Terelius, M Hassan, ... The pharmacogenomics journal 3 (1), 53-61, 2003 | 274 | 2003 |
| Biodegradable polymeric vesicles containing magnetic nanoparticles, quantum dots and anticancer drugs for drug delivery and imaging F Ye, Å Barrefelt, H Asem, M Abedi-Valugerdi, I El-Serafi, M Saghafian, ... Biomaterials 35 (12), 3885-3894, 2014 | 266 | 2014 |
| Busulfan bioavailability M Hassan, P Ljungman, P Bolme, O Ringden, Z Syruckova, A Bekassy, ... | 264 | 1994 |
| Association of busulfan exposure with survival and toxicity after haemopoietic cell transplantation in children and young adults: a multicentre, retrospective cohort analysis IH Bartelink, A Lalmohamed, EML van Reij, CC Dvorak, RM Savic, ... The Lancet Haematology 3 (11), e526-e536, 2016 | 263 | 2016 |
| Pharmacokinetics of high-dose busulphan in relation to age and chronopharmacology M Hassan, G Öberg, AN Bekassy, J Aschan, H Ehrsson, P Ljungman, ... Cancer chemotherapy and pharmacology 28, 130-134, 1991 | 194 | 1991 |
| Pharmacokinetic and metabolic studies of high-dose busulphan in adults M Hassan, G Öberg, H Ehrsson, M Ehrnebo, I Wallin, B Smedmyr, ... European journal of clinical pharmacology 36, 525-530, 1989 | 187 | 1989 |
| Endometrial endothelial cells are derived from donor stem cells in a bone marrow transplant recipient M Mints, M Jansson, B Sadeghi, M Westgren, M Uzunel, M Hassan, ... Human reproduction 23 (1), 139-143, 2008 | 186 | 2008 |
| On the bioavailability of oral and subcutaneous 2-chloro-2'-deoxyadenosine in humans: alternative routes of administration. J Liliemark, F Albertioni, M Hassan, G Juliusson Journal of Clinical Oncology 10 (10), 1514-1518, 1992 | 179 | 1992 |
| The effect of busulphan on the pharmacokinetics of cyclophosphamide and its 4-hydroxy metabolite: time interval influence on therapeutic efficacy and therapy-related toxicity M Hassan, P Ljungman, O Ringden, Z Hassan, G Öberg, C Nilsson, ... Bone marrow transplantation 25 (9), 915-924, 2000 | 177 | 2000 |
| Improved survival after allogeneic hematopoietic stem cell transplantation in recent years. A single-center study M Remberger, M Ackefors, S Berglund, O Blennow, G Dahllöf, A Dlugosz, ... Biology of Blood and Marrow Transplantation 17 (11), 1688-1697, 2011 | 168 | 2011 |
| SERS quantification and characterization of proteins and other biomolecules N Feliu, M Hassan, E Garcia Rico, D Cui, W Parak, R Alvarez-Puebla Langmuir 33 (38), 9711-9730, 2017 | 164 | 2017 |
| Personalizing busulfan-based conditioning: considerations from the american society for blood and marrow transplantation practice guidelines committee J Palmer, JS McCune, MA Perales, D Marks, J Bubalo, M Mohty, ... Biology of Blood and Marrow Transplantation 22 (11), 1915-1925, 2016 | 156 | 2016 |
Ibrahim El SerafiAssociate professor, Basic Medical Sciences Department, College of Medicine, Ajman UniversityZweryfikowany adres z ajman.ac.ae